HLTH - VanEck Vectors Global Healthcare Leaders ETF

VanEck Blog & Insights

VanEck Vectors Global Healthcare Leaders ETF HLTH

Fund description: HLTH gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index. 

Index description: The MarketGrader Developed Markets (ex-Australia) Health Care Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.

Management style:  Replication

 as at 26-Oct-20

  • Exchange

    ASX
  • ASX code

    HLTH
  • Bloomberg index code

    MGHCAUNR
  • Index provider

    MarketGrader
  • NAV1

    $10.40
  • Units outstanding1

    2,000,000
  • Net assets1

    $20.8M
  • Number of holdings1

    50
  • Inception date2

    08-Sep-20
  • ASX commencement

    10-Sep-20
1As of the close of the previous trading day.
2The date the ETF was seeded prior to quotation on ASX.

as at 26-Oct-20

*The NAV is generally calculated daily after all markets are closed for that day based on the closing price of the securities on the relevant foreign stock exchange. The NAV is then converted to AUD based on the relevant London WM Reuters 4pm exchange rate. This means, due to Australia’s time zone, that the NAV will generally not be updated until around 12pm next business day. 

 

Key points

Underlying Index 
MarketGrader Developed Markets (ex-Australia) Health Care Index.

Overview
The Index consists of 50 fundamentally sound companies with the best growth at a reasonable price (GARP) attributes in the healthcare sector from developed markets excluding Australia.

Summary of Index methodology
The Index seeks to identify the largest companies in the health care sector with the best growth at a reasonable price (GARP) attributes, being the best drivers of long-term capital appreciation. The Index constituents are selected on the basis of the strength of their fundamentals across four factor categories: growth, value, profitability and cash flow. The 50 Index constituents are equally weighted at each semi-annual rebalance.

Rebalances
The Index is reviewed and rebalanced on a semi-annual basis, usually as of the close of the third Friday of March and September.

Index provider
MarketGrader.com Corporation ('MarketGrader'). MarketGrader is not a related body corporate of VanEck.

"MarketGrader" and "MarketGrader Developed Markets (Ex-Australia) Health Care Index" are trademarks of MarketGrader.com Corp. and have been licensed for use for certain purposes by VanEck. HLTH is based on the MarketGrader Developed Markets (ex-Australia) Health Care Index, but is not sponsored, endorsed, sold or promoted by MarketGrader, and MarketGrader makes no representation regarding the advisability of investing in HLTH.

Index profile  

  • Bloomberg index code

    MGHCAUNR
  • Launch date

    14-Aug-20
  • Base date

    31-Dec-07
  • Rebalance Frequency

    Semi-annually

Top ten index constituents (%) Download all daily index constituents as at 30-Sep-20

Total constituents: 50
Constituent name
Ticker
Weightings (%)
DIASORIN SPA
DIA IM
2.30
HOLOGIC INC
HOLX US
2.24
PERKINELMER INC
PKI US
2.17
HOYA CORP
7741 JP
2.17
HORIZON PHARMA INC
HZNP US
2.16
STERIS PLC
STE US
2.15
MASIMO CORPORATION
MASI US
2.13
THERMO FISHER SCIENTIFIC INC
TMO US
2.11
ICON PLC
ICLR US
2.10
IDEXX LABORATORIES INC
IDXX US
2.09
Top ten total (%) 21.62
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Index country weightings (%) as of 30-Sep-20

  • Country

    Weightings (%)
  • United States

    64.6
  • Japan

    10.0
  • Italy

    4.2
  • Denmark

    4.1
  • Switzerland

    3.9
  • South Korea

    3.3
  • Ireland

    2.1
  • France

    2.0
  • New Zealand

    1.9
  • United Kingdom

    1.9
  • China

    1.9
  • Total

    99.9

Index sector weightings (%) as at 30-Sep-20

  • Sector

    Weightings (%)
  • Pharmaceuticals, Biotechnology

    67.2
  • Health Care Equipment & Services

    32.8
  • Total

    100.0